J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...

Our opinions are our own. Here is a list of our partners and here's how we make money. Square is one of a few providers in the space that offers a free version of its POS system. The free version ...

Shares of GSK PLC GSK inched up 0.94% to £14.01 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.28% to 8,557.81. GSK ...

GSK PLC GSK shares advanced 3.35% to £14.02 Monday, on what proved to be an all-around great trading session for the stock ...

I believe the company’s currently unprofitable so I question that PEG ratio. GSK, with upcoming RSV vaccine developments and a forward P/E ratio of 10 — the lowest in five years, looks accurate.

Learn More Pharmaceutical giant GSK is pushing the boundaries of what generative AI can achieve in healthcare areas like scientific literature review, genomic analysis and drug discovery.

Lenox Square and Atlanta Ronald McDonald House Charities have teamed up to help keep children warm this winter. Now through Jan. 31, Lenox Square is hosting a coat drive, benefiting children ...

They've got the perfect blend of modern appeal and functionality. Whether crafting a sleek website or designing a logo, these options will elevate your designs. So, which one will you choose? After ...

The retail chain announced "a comprehensive brand refresh" in a news release on Monday, Jan. 13. It's the first logo change for the 63-year-old company since it removed the star between "Wal" and ...